SS Innovations International (NASDAQ:SSII – Get Free Report) is one of 511 public companies in the “Healthcare Equipment & Supplies” industry, but how does it contrast to its rivals? We will compare SS Innovations International to related businesses based on the strength of its risk, valuation, profitability, earnings, analyst recommendations, dividends and institutional ownership.
Valuation & Earnings
This table compares SS Innovations International and its rivals revenue, earnings per share and valuation.
| Gross Revenue | Net Income | Price/Earnings Ratio | |
| SS Innovations International | $42.49 million | -$12.13 million | -35.17 |
| SS Innovations International Competitors | $1.88 billion | $139.14 million | 9.47 |
SS Innovations International’s rivals have higher revenue and earnings than SS Innovations International. SS Innovations International is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.
Risk and Volatility
SS Innovations International has a beta of -1.52, suggesting that its share price is 252% less volatile than the S&P 500. Comparatively, SS Innovations International’s rivals have a beta of 5.35, suggesting that their average share price is 435% more volatile than the S&P 500.
Profitability
This table compares SS Innovations International and its rivals’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| SS Innovations International | -23.73% | -26.77% | -15.01% |
| SS Innovations International Competitors | -278.24% | -150.08% | -21.87% |
Analyst Recommendations
This is a breakdown of current ratings for SS Innovations International and its rivals, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| SS Innovations International | 1 | 0 | 0 | 0 | 1.00 |
| SS Innovations International Competitors | 4275 | 10549 | 18323 | 829 | 2.46 |
SS Innovations International currently has a consensus target price of $7.00, suggesting a potential upside of 231.75%. As a group, “Healthcare Equipment & Supplies” companies have a potential upside of 21.32%. Given SS Innovations International’s higher probable upside, equities research analysts clearly believe SS Innovations International is more favorable than its rivals.
Insider and Institutional Ownership
40.5% of shares of all “Healthcare Equipment & Supplies” companies are owned by institutional investors. 14.8% of shares of all “Healthcare Equipment & Supplies” companies are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
Summary
SS Innovations International rivals beat SS Innovations International on 9 of the 13 factors compared.
About SS Innovations International
AVRA Medical Robotics, Inc. develops and manufactures medical surgical devices. The company has a research agreement with the University of Central Florida to develop navigation and control technologies with applications in medical robotics. The company was formerly known as AVRA Surgical Microsystems, Inc. and changed its name to AVRA Medical Robotics, Inc. in November 2015. AVRA Medical Robotics, Inc. was founded in 2015 and is based in Orlando, Florida.
Receive News & Ratings for SS Innovations International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SS Innovations International and related companies with MarketBeat.com's FREE daily email newsletter.
